The four studies have achieved the businesss enrollment targets.

Alexion Pharmaceuticals completes enrollment in Soliris clinical research for aHUS Alexion Pharmaceuticals, Inc. The four studies have achieved the business’s enrollment targets, with a complete of 35 adult and adolescent patients with aHUS approximately. We anticipate presenting preliminary results from these studies afterwards in 2010?.Specifically, the British charity Save the small children, which is working the first U.K.-built treatment center to open, has been criticized for a gradual and disorganized rollout. On Monday The charity defended its actions, stating that it stepped into a role at the Kerry Town center that no one else needed and that it offers said all along that it does not have knowledge running an Ebola ward. It stated it is opening more beds slowly, as is considered the best practice.